Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04968041
Other study ID # STUDY00000111
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 27, 2019
Est. completion date August 30, 2020

Study information

Verified date August 2023
Source Florida State University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The intervention program proof-of-concept was assessed as a single-arm, within-subjects clinical study with a target enrollment of 10 participants with possible or probable amnestic MCI. The protocol required participants to complete a pre-intervention assessment within two weeks of beginning the intervention, attend seven, one-hour intervention group sessions across six weeks, complete a post-assessment and interview in the final week of the intervention, and complete weekly surveys throughout the intervention.


Description:

The primary goal of the proof-of-concept phase is to use pre-post comparisons to determine if the treatment package can produce clinically significant improvements. Thus, our goal was to assess whether the MI-CBT KNA program influenced adherence to KN and cognitive outcomes. Of note, recruitment for the trial occurred in the weeks leading up to the COVID-19 pandemic, which substantially altered the original intervention and assessment design due to restrictions on in-person human subject research. While the original protocol included in-person assessments and group meetings, collection of multiple biological samples (i.e., lipid panels, basic vitals, inflammatory biomarkers), and weekly health assessments, these in-person components were modified or removed for completion during the COVID-19 pandemic. Pre-assessment and screening appointments described below were completed in-person prior to the COVID-19 pandemic. Thus, we completed pre-intervention neuropsychological assessments with participants at baseline prior to beginning the trial; however, immediately following baseline assessments, we fully revised the protocol to include only online, video, and phone contact. We moved the KNA program to an online platform (HIPAA-compliant Zoom), and assessments were changed to online surveys and video assessments. Individual testing of the video platform was completed prior to the trial, which successfully reduced technical problems. The MI-CBT KNA Program proof-of-concept was assessed as a single-arm, within-subjects clinical study with a target enrollment of 10 participants with possible or probable amnestic MCI. The protocol required participants to complete a pre-intervention assessment within two weeks of beginning the intervention, attend seven, one-hour intervention group sessions across six weeks, complete a post-assessment and interview in the final week of the intervention, and complete weekly surveys throughout the intervention. Participants were mailed materials, including the participant workbook and food, macronutrient, and ketone logs. Participants were also sent two bottles of ketone urine test strips for daily testing and materials to complete follow-up assessments. Throughout the program, participants were instructed to titrate into full ketosis across the first four weeks of the program by gradually reducing total carbohydrate intake and increasing healthy fat intake (e.g., fish, nuts, avocado, olive oils etc.). Thus, participants were not expected to attain measurable ketone levels until the final weeks of the program.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date August 30, 2020
Est. primary completion date June 30, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 60 Years to 75 Years
Eligibility Inclusion Criteria: - Final inclusion criteria included individuals who met criteria for "possible" Mild cognitive impairment (MCI), which was defined as the following: evidence of either subjective decline in memory and greater self-reported use of compensatory strategies OR poorer performance than expected in one or more cognitive domain OR limited evidence of impairment in both subjective and objective findings. Exclusion Criteria: - Presence of severe and/or unstable medical conditions - diagnosable major neurocognitive disorder

Study Design


Intervention

Behavioral:
Motivational Interviewing-Cognitive Behavioral Therapy Ketogenic Nutrition Adherence Program
The intervention using strategies from motivational interviewing and cognitive behavioral therapy to promote motivation and adherence to ketogenic nutrition in older adults at high risk for Alzheimer's disease. The program is a 6-week, group program led by a psychologist and nutrition expert.

Locations

Country Name City State
United States Florida State University Tallahassee Florida

Sponsors (1)

Lead Sponsor Collaborator
Florida State University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Ketogenic Adherence Assessed based on reported ketone levels during the program (reporting at least one day or greater with trace amounts of ketones) using urinalysis ketone test strips administered at home by participants. 6-weeks
Primary Acceptability Assessed based on qualitative feedback and online surveys described here: https://pilotfeasibilitystudies.biomedcentral.com/articles/10.1186/s40814-022-00970-z.
Participants also rated how well they felt the program helped them achieve their health-related goals 0 (none) to 3 (all).
6-weeks
Primary Retention Assessed based on attendance and % of participants who remained in the program from start to finish baseline to 6-weeks
Secondary Cognitive Functioning Assessed using the total scaled score (age-normed) of the Repeatable Battery for the Assessment of Neuropsychological Status - Update. A score of 100 is considered "average" (50th percentile), and higher scores are considered better cognitive functioning. The outcome reported is the actual value at 6-weeks, rather than a change score. Baseline and 6-weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04262206 - Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults Phase 4
Active, not recruiting NCT04051918 - Robot-assisted Cognitive Training for Lonely Older Adults With Mild Cognitive Impairment (MCI) N/A
Completed NCT05544201 - Transcranial Alternating Current Stimulation (TACS) for Sleep Disturbances in Neurocognitive Disorders Due to Alzheimer's Disease N/A
Recruiting NCT03165396 - Appropriate Compatibility of Propofol and Sevoflurane for Orthopaedic Surgery of Patients With MCI N/A
Recruiting NCT05201534 - Interventions in Mathematics and Cognitive Skills N/A
Not yet recruiting NCT04863378 - Efficacy of a Multimodal Brain Health Intervention for Older African Americans N/A
Recruiting NCT06182995 - Anticipating Decline and Providing Therapy N/A
Recruiting NCT05200572 - Study of a Behavioral Intervention for Older Advanced Cancer Patients and Their Caregivers N/A
Completed NCT05892861 - The Effect of Multidomain Dietary Education in Type 2 Diabetic Adults N/A
Completed NCT04317612 - Effect of Nordic Berries on Cognitive Function, Cardiometabolic Risk Markers and Gut Microbiota in Adults With Mild Cognitive Impairment N/A
Completed NCT03653351 - Brain Stimulation and Enhancing Cognition in Older Adults N/A
Suspended NCT03755570 - How is COGNItive Function Affected by Cardiac Resynchronisation Therapy?
Completed NCT04440969 - Evaluation of Pilot Community-based Multi-domain Program Older Adults at Risk of Cognitive Impairment N/A
Completed NCT04200911 - Cognition, Age, and RaPamycin Effectiveness - DownregulatIon of thE mTor Pathway Early Phase 1
Recruiting NCT06192433 - Repeated Transcranial Magnetic Stimulation in the Elderly With Cognitive Impairment N/A
Recruiting NCT04032626 - MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients Phase 2
Completed NCT05922319 - Effects of Training Dose on Computerized Cognitive Training in Patients With Cognitive Impairment
Completed NCT03384043 - Comparing Smartphone Technology and a Memory Strategy on Improving Prospective Memory in Alzheimer's Disease N/A
Completed NCT04498195 - Walking on Cognitive Function in Individuals With Mild Cognitive Impairment: A Pilot Project N/A
Active, not recruiting NCT03170492 - Does Computerized Cognitive Training Improve Executive Functioning in the Older Adult? N/A